Stocktoria
TANDEM DIABETES CARE INC TNDM
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2013-11-13
TANDEM DIABETES CARE INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 53.8% | 52.1% | 49.2% | 51.5% | 53.5% |
| Operating margin | -18.5% | -10.5% | -31.2% | -11.6% | 3.2% |
| Net margin | -20.2% | -10.2% | -29.8% | -11.8% | 2.2% |
| FCF margin | -2.9% | 0.5% | -7.8% | 2.0% | 13.8% |
| Return on assets | -23.2% | -9.9% | -23.4% | -9.0% | 1.7% |
| Return on equity | -131.9% | -36.5% | -71.0% | -21.5% | 3.6% |
| Debt / equity | 2.00× | 1.17× | 0.91× | — | — |
| Current ratio | 2.55 | 2.93 | 3.83 | 5.14 | 6.15 |
| Revenue growth | 7.9% | 25.7% | -6.7% | 14.0% | 40.9% |
Source: SEC EDGAR filings · CIK 0001438133 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.